Columbia, MO, United States of America

Hannah Alexander

This inventor holds 4 USPTO granted patents. Top assignees: University of Missouri, Scripps Clinic and Research Foundation, Scripps Research Institute. Active years: 1988-2005.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • San Diego, CA (US) (1988)
  • Columbia, MO (US) (1996 - 2005)

Company Filing History:


Years Active: 1988-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hannah Alexander

Introduction

Hannah Alexander is a notable inventor based in Columbia, MO (US). She has made significant contributions to the field of cancer research, holding a total of 4 patents. Her work focuses on developing methods for screening novel agents that can be used in cancer therapy and prevention.

Latest Patents

One of her latest patents involves methods of screening agents for cancer therapeutic and prophylactic activity. This invention provides a framework for examining the expression of genes in the Nucleotide Excision Repair (NER) and Base Excision Repair (BER) pathways. In particular embodiments, cells of the cellular slime mold are contacted with candidate agents, allowing researchers to analyze the activity of genes such as the helicases repB and repD, as well as the apurinic-apyrimidinic endonuclease APE.

Career Highlights

Hannah has worked with esteemed institutions such as the University of Missouri and the Scripps Clinic and Research Foundation. Her research has contributed to advancements in cancer treatment methodologies, showcasing her dedication to improving health outcomes.

Collaborations

Throughout her career, Hannah has collaborated with notable colleagues, including Ann M Moriarty and Richard A Lerner. These partnerships have further enriched her research and innovation efforts.

Conclusion

Hannah Alexander's work exemplifies the impact of innovative research in the fight against cancer. Her patents and collaborations highlight her commitment to advancing therapeutic strategies, making her a significant figure in the field of cancer research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…